Conference: 60th European Renal Association (ERA) Congress

Date: 15–17 June 2023

Location: Milan, Italy

MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.

The following MDPI journals will be represented:

• JCM;
• JPM;
• Kidney and Dialysis;
• Diagnostics;
• Clinics and Practice;
• Uro;
• Cells;
• BioChem;
• Transplantology.

Conference: 19^th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19^th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

• Metabolites;
• Agronomy;
• Antioxidants;
• Applied Biosciences;
• BioMed;
• BioMedInformatics;
• Biomolecules;
• Cancers;
• Cells;
• Children;
• CIMB;
• Diseases;
• Foods;
• Genes;
• JPM;
• Nutrients;
• Plants.

Please do not hesitate to reach out (metabolites@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.

Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA

MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.

The following MDPI journals will be represented:

• JCM;
• Medicina;
• Clinics and Practice;
• JPM;
• Cancers;
• Medicines;
• Healthcare;
• Metabolites;
• Children;
• Brain Sciences.

If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.

Conference: 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023)
Date: 29 June–1 July 2023
Location: Copenhagen, Denmark

MDPI will be attending ESCAP 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Child and Adolescent Psychiatry. The theme of the conference is “Mental health of children and adolescents”. At the conference, specialists will share and discuss the latest research and applications of environmental and chemical substances in relation to society.

The following MDPI journals will be represented:

• Children;
• Behavioral Sciences;
• JCM;
• JPM;
• Medicina;
• Adolescents;
• Disabilities.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escap2023.eu/.

Metabolic syndrome pathophysiology is multifactorial and involves abdominal obesity, hyperinsulinemia, and hyperglycemia. The activation of lipoprotein lipase and the inhibition of secretion of very low-density lipoproteins are central factors. Atherogenic dyslipidemia is causally linked to cardiovascular disease. At the same time, there is new evidence regarding genetic predisposition in metabolic syndrome causation. From early studies on twins to genome-wide association studies, the genetic origin of metabolic syndrome was found to span different genetic loci. Thus, environmental factors play a key role. Knowledge of increased genetic susceptibility to the syndrome permits a personalized approach to treatment and prevention. In this context, oxidative stress augments and Nrf-2 pathways are involved, the activation of which are equally favorable targets for oxidative stress suppression after treatment with natural product derivatives and phytotherapy. This attempt can also reduce the costs and side effects.

In the current webinar, firstly, lipid metabolism dysfunction in the pathogenesis of metabolic syndrome will be discussed. Genes and metabolic syndrome heritability will be analyzed, focusing on specific genes along with interaction with environmental factors. Last but not least, specific benefits from natural products’ utilization in the treatment of metabolic syndrome will be presented along with molecular pathways modification and cell signal regulation from phytotherapy.

Date: 26 April 2023 at 10:00 a.m. CEST
Webinar ID: 843 2926 3596

Register now for free!

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available to watch.

Webinar Chair and Keynote Speakers:

• Dr. Konstantinos Tsarouhas, Department of Cardiology, University Hospital of Larissa, Larissa, Greece.
• Dr. Genovefa Kolovou, Preventive Cardiology, Lipoprotein apheresis Unit and Lipid Disorders Clinic, Metropolitan Hospital, Athens Greece.
• Dr. Lina Florentin, A-Lab Genetic and Genomic Centre, Athens, Greece.
• Dr. Ramin Rezaee, International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Assistant Professor.

Relevant Special Issue:

• “Metabolic Syndrome and Cardiovascular Disease”
  Edited by Dr. Konstantinos Tsarouhas

MDPI will be attending the European Human Genetics Conference 2023 (ESHG 2023), held in Glasgow, UK, from 10 to 13 June 2023.

The following MDPI journals will be represented:

• Genes;
• IJMS;
• JPM;
• Applied Biosciences;
• MPs;
• Symmetry;
• Toxics;
• Cells;
• IJNS.

If you plan on attending this conference, feel free to stop by our booth #824. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link: https://2023.eshg.org/.

Conference: The 112th Annual Meeting of the Japanese Society of Pathology
Date: 13–15 April 2023
Place: Shimonoseki, Japan

MDPI will be attending the 112th Annual Meeting of the Japanese Society of Pathology as an exhibitor. This meeting will be held in Shimonoseki, Japan, from 13 to 15 April 2023. This conference is held every year, and the theme of the 112th edition is “Doors to Overcoming Intractable Diseases: Potential of Pathology and Pathological Diagnostics”. The aim of this meeting is to provide an opportunity for all the members who chose the path of pathology to engage in hot discussions and introduce new perspectives to pathology and diagnostic pathology.

The following MDPI journals will be represented:

• Cancers;
• Diagnostics;
• JPM;
• Pathogens;
• CIMB;
• Pathophysiology.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://site2.convention.co.jp/112jsp/english/.

This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.

Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.

The following MDPI journals will be represented:

• Pharmaceuticals (leading journal);
• Biomedicines;
• JPM;
• JCM;
• Marine Drugs;
• Children;
• Current Oncology;
• BioMedInformatics;
• JoX;
• Rheumato.

If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at pharmaceuticals@mdpi.com.

MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

• Biomedicines;
• Cancers;
• Cells;
• Diagnostics;
• Current Oncology;
• JPM;
• JCM;
• Onco;
• CIMB;
• BioMedInformatics.

If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

Journal of Personalized Medicine (JPM; ISSN: 2075-4426) is an international journal published monthly online by the leading open access publisher MDPI with Prof. Dr. David Alan Rizzieri serving as the Editor-in-Chief. JPM publishes cutting-edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, and ‘omics association analysis). To ensure the continued efficient and high-quality production of our journal, we are currently seeking nominations and applications for the position of Co-Editor-in-Chief to assist Prof. Dr. David Alan Rizzieri.

The responsibilities of the Co-Editor-in-Chief include the following:

• Advising on the strategic development of the journal;
• Nominating/inviting Guest Editors and optionally delegating to them the authority to make final acceptance decisions for submitted articles;
• Nominating and leading the Editorial Board;
• Promoting the journal at scientific conferences or through other venues.

As an Co-Editor-in-Chief, you will have the unique opportunity to network and communicate with scholars in the personalized medicine community, building long-term relationships and establishing your influence within your discipline. Appointed members will also receive an Editor Certificate confirming this role. In addition, you will have the opportunity to publish two paper per year free of charge in JPM. The term for this position is two years and can be renewed.

If you are a researcher in a related field and are passionate about participating in the publication of cutting-edge research, please do not hesitate to get in touch about joining the Editorial Board (https://www.mdpi.com/journal/jpm). To apply for this position, please contact the Journal of Personalized Medicine Editorial Office (jpm@mdpi.com) with the following two files attached:

• A full academic CV;
• A short cover letter that details your interests and enthusiasm for the position.

JPM Editorial Office

The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) editorial team is pleased to announce the launch of a new Section, “Life-Stage-Specific Medicine (LSSM)”. The aim of this Section is to offer a platform for researchers and professionals in the field of personalized medicine on which they can demonstrate the influence of genetic and environmental factors on different life stages, in addition to how different life stages affect disease development, treatments, and longevity.

Topics could include, but are not limited to, the following:

• Disease development of different life stages and responses to disease treatments;
• Hormone levels in different life stages and their impact on disease development and treatments;
• The immune system at different life stages and its relationship with disease development, drugs, and disease treatments;
• Changes in hormone levels and immune statements during translations of life stages;
• How the length of life stages affects the total lifespan of humans;
• Clinical practice, clinical trials, and drug dosages with regard to the principal law of lifespan (PLOSP);
• Racial and sex differences in terms of life stages and lifespan;
• Menopause; puberty; and reproduction.

We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at jpm@mdpi.com. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/786489cd3ae44f21e922b7fa879d33fc?form%5Bjournal_id%5D=65.

JPM Editorial Office

Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan

MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.

The following MDPI journals will be represented:

• Biomedicines;
• JPM;
• Pharmaceutics;
• JCM;
• Pharmaceuticals.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

Conference: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Cardiogenetics;
• Bioengineering;
• Biomolecules;
• Metabolites;
• Cells;
• Symmetry;
• Biomedicines;
• Computers;
• COVID;
• Epigenomes.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.

The following MDPI journals will be represented:

• Children (leading journal);
• JPM;
• Medicina;
• Audiology Research;
• JCM;
• Healthcare;
• Diagnostics;
• Metabolites;
• Cancers;
• Nutrients. 

If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have. 

For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.

We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.

This program intends to provide an opportunity for early career scientists to enhance their editing, networking, and organizational skills, and to work closely with our journal to gain more editorial experience. Early career scientists who have novel ideas for new Special Issues in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Editorial Board of JPM, or from other well-established research institutes or laboratories.

If you are interested in this opportunity, please send your Special Issue proposal to the JPM Editorial Office (jpm@mdpi.com), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, JPM will continue to welcome all Special Issue proposals based on hot research topics.

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is an international, peer-reviewed, open access journal on personalized medicine that is published monthly online by MDPI. To develop different research areas and continue to attract high-quality papers, JPM is recruiting Section Editors-in-Chief. More details can be found at https://www.mdpi.com/journal/jpm/sections.

At present, the following Sections have not yet found suitable scholars to lead them:

• “Regenerative Medicine and Therapeutics”;
• “Epigenetic Therapy”;
• “Sex, Gender and Hormone Based Medicine”.

We are now recruiting Section Editors-in-Chief (SEiC) for these Sections. If you are an active researcher in one of the aforementioned fields and are passionate about publishing cutting-edge research, please do not hesitate to contact us at: jpm@mdpi.com/iris.qiao@mdpi.com. You can find more information on our homepage: https://www.mdpi.com/journal/jpm.

The Section Editor-in-Chief has the following responsibilities:

• Making decisions on whether a manuscript can be accepted based on the reports we collect;
• Reviewing a small number of papers per year and managing the Section together with other journal editors;
• Promoting JPM and increasing its visibility at related academic conferences.

We believe that by combining our rigorous editorial policies with your expertise, we can build a high-quality journal. We thank you in advance for your interest and look forward to collaborating with you in the future.

JPM Editorial Office

MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Biomedicines;
• Biomolecules;
• Cardiogenetics;
• Cancers;
• Brain Science;
• Symmetry;
• Diagnostics;
• Metabolites;
• Cells;
• Biology;
• Humans;
• DNA.

If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link:

https://www.ashg.org/meetings/2022-annual-meeting/.

MDPI will be attending EuroBioFilms 2022 (EBF), hosted by the ESCMID Study Group for Biofilms (ESGB), which will be held from 31 August to 3 September 2022 in Palma de Mallorca, Spain. The conference will be held at the Meliá Palma Marina Hotel, Av. de Gabriel Roca, 29, 07014 Palma, Balearic Islands.

The multidisciplinary program will cover many subjects and will be a mix of basic and clinical biofilm-related topics. Leading scientists in the field will be present as keynote speakers and/or chairpersons. Oral presentations will be presented during various parallel sessions. On 31^st of August, several educational preconference workshops will be organized.

The following MDPI journals will be represented:

• Antibiotics (leading);
• Pathogens;
• Membranes;
• Biology;
• Journal of Personalized Medicine.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following link: https://eurobiofilms2022.com/, or contact the Antibiotics Editorial Office at antibiotics@mdpi.com.

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

• Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

• Shawn Alexander Hallett, University of Michigan, USA

Medicines:

• Claire Albert, Yale University, USA

Pharmaceuticals:

• Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
• Patrick Jim Küppers, University Hospital Bonn, Germany

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

• Antonio G. Solimando, University of Bari Aldo Moro, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Joaquim Carreras, Tokai University, Japan
• Pierfrancesco Franco, University of Turin School of Medicine, Italy
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

• Margaret Fitch, University of Toronto, Canada
• Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

• Naser Alsharairi, Griffith University, Australia
• Peter W. Choate, Mount Royal University, Canada
• Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

• Giulio Francesco, Sapienza University of Rome, Italy
• Sebastian Schnaubelt, Medical University of Vienna, Austria
• Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

• Onofrio Laselva, University of Foggia, Italy
• Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
• Vladimir Vladimirov, Virginia Commonwealth University, USA
• Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

• Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

• Anjul Khadria, California Institute of Technology, Pasadena, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials”

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

• “Antibiotic Discovery: Where Have We Come from, Where Do We Go?”

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

• “Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients”

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

• “Treatment of Peri-Implant Mucositis with Repeated Application of Chlorhexidine Chips or Gel during Supportive Therapy—A Randomized Clinical Trial”

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

• “Two-Year Use of Care Robot Zora in Dutch Nursing Homes: An Evaluation Study”

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

• “The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus”

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

• “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

• “The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity”

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

• “Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR”

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

• “Tumor Microenvironment”

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

• “Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study”

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

• “3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology”

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

• “Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems”

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Source: 2021 CiteScores™ (Elsevier)

Date: 15 June 2022
Time: 14:30 (CEST)
Webinar ID: 871 1746 2760
Register here: https://jpm-1.sciforum.net/
Participation fee: None
Language: English
Webinar keywords: radiation, radiotherapy, sensitivity, radiation oncology, biomarkers, cancer, X-rays
Link to related Special Issue: https://www.mdpi.com/journal/jpm/special_issues/radiation_cancer

Webinar Chair and Speakers:

Chair:

• Dr. Christophe Badie, Cancer Mechanisms and Biomarkers Group, UK Health Security Agency, Harwell Campus, UK

Speakers:

• Dr. Elisa Placidi, UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, Italy
• Prof. Dr. Susan M. Bailey, Department of Environmental & Radiological Health Sciences, Cancer Biology & Comparative Oncology University Program of Research and Scholarly Excellence, Colorado State University, USA

If you have any questions about this webinar, please contact jpm.webinar@mdpi.com.

We look forward to your participation in this event.

JPM Editorial Office

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426):

Name: Dr. Cristian Ripoli
Affiliation: Department of Neuroscience, Faculty of Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy

Name: Dr. Jeonghyun Ahn
Affiliation: Department of Cell Biology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA 

Name: Dr. Sheng Ho
Affiliation: Department of Radiation Oncology, Chi Mei Medical Center, Graduate Institute of Medical Science, Chang Jung Christian University, Tainan 710, Taiwan

Name: Dr. Ming-Chao Tsai
Affiliation: 1. Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
2. Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 83301, Taiwan

Name: Dr. Erik Wilms
Affiliation: Hospital Pharmacy, The Hague Hospitals, 2545 AB The Hague, The Netherlands

Name: Dr. Sara Bravaccini
Affiliation: IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, via Maroncelli 40, 47014 Meldola, Italy

Name: Prof. Dr. Giovanni Squadrito
Affiliation: Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy

Name: Prof. Dr. Alfredo Berruti
Affiliation: Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica, Brescia, Italy 

Name: Prof. Dr. Cheng-Hsien Lu
Affiliation: 1. Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung and Chang Gung University 123, Ta-Pei Road, Niao Sung district, Kaohsiung City 83304, Taiwan
2. Department of Biological Science, National Sun Yat-sen University, Kaohsiung City 80424, Taiwan

Name: Dr. Ceres Fernandez Rozadilla
Affiliation: 1. Grupo de Medicina Xenómica, Universidade de Santiago de Compostela (USC), 15706 Santiago de Compostela, Spain
2. Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain

Name: Dr. Francesca Stillitano
Affiliation: Cardiovascular Department, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands

Name: Dr. Hui-Hua Hsiao
Affiliation: Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Name: Prof. Dr. Juan J. Salazar Corral
Affiliation: Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Departamento Oftalmología y ORL, Universidad Complutense de Madrid, Madrid, Spain

Name: Dr. Margarida Maria Fernandes Baptista e Silva
Affiliation: Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal

Name: Dr. Sara Llufriu
Affiliation: Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain

Name: Prof. Dr. Won Hyuk Chang
Affiliation: Department of Physical & Rehabilitation Medicine, Center for Prevention and Rehabilitation, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea

Name: Dr. Mircea Tampa
Affiliation: Department of Dermatology, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania

We wish them every success both in their research and in the development of the journal.

Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/jpm/editors. 

JPM Editorial Office

We are pleased to announce the list of the Top 10 Cited Papers published in 2020 and 2021 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426):

1. “Wise Management of Ovarian Cancer: On the Cutting Edge”
by Stergios Boussios, Christos Mikropoulos, Eleftherios Samartzis, Peeter Karihtala, Michele Moschetta, Matin Sheriff, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy and Nicholas Pavlidis

2. “XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma”
by Nguyen Quoc Khanh Le, Duyen Thi Do, Fang-Ying Chiu, Edward Kien Yee Yapp, Hui-Yuan Yeh and Cheng-Yu Chen

3. “Applications of Machine Learning Predictive Models in the Chronic Disease Diagnosis”
by Gopi Battineni, Getu Gamo Sagaro, Nalini Chinatalapudi and Francesco Amenta

4. “Molecular and Cellular Mechanisms Affected in ALS”
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya Geetha Vijayakumar, William J. Duddy and Stephanie Duguez

5. “A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration”
by Vincenzo D’Agostino, Ferdinando Caranci, Alberto Negro, Valeria Piscitelli, Bernardino Tuccillo, Fabrizio Fasano, Giovanni Sirabella, Ines Marano, Vincenza Granata, Roberta Grassi, Davide Pupo and Roberto Grassi

6. “Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis”
by Irina N. Grigor’eva

7. “A Research on the Classification and Applicability of the Mobile Health Applications”
by Ivan Miguel Pires, Gonçalo Marques, Nuno M. Garcia, Francisco Flórez-Revuelta, Vasco Ponciano and Salome Oniani

8. “The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects”
by Hiroshi Maeda

9. “Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network”
by Georgia L. Wiesner, Alanna Kulchak Rahm, Paul Appelbaum, Sharon Aufox, Sarah T. Bland, Carrie L. Blout, Kurt D. Christensen, Wendy K. Chung, Ellen Wright Clayton, Robert C. Green, Margaret H. Harr, Nora Henrikson, Christin Hoell, Ingrid A. Holm, Gail P. Jarvik, Iftikhar J. Kullo, Philip E. Lammers, Eric B. Larson, Noralane M. Lindor, Maddalena Marasa, Melanie F. Myers, Josh F. Peterson, Cynthia A. Prows, James D. Ralston, Hila Milo Rasouly, Richard R. Sharp, Maureen E. Smith, Sara L. Van Driest, Janet L. Williams, Marc S. Williams, Julia Wynn and Kathleen A. Leppig

10. “Biomarkers for Alzheimer’s Disease Early Diagnosis”
by Eva Ausó, Violeta Gómez-Vicente and Gema Esquiva

Further details about the Top 10 Cited Papers can be found at the following link:
https://www.mdpi.com/journal/jpm/stats.

JPM Editorial Office

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine (ISSN: 2075-4426):

Name: Prof. Dr. Ping-Ho Chen
Affiliation: School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, No. 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan

Name: Dr. Waqar Rashid
Affiliation: Medical School, University of Sussex, Brighton, UK

Name: Prof. Dr. Richard Rokyta
Affiliation: Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen, Charles University,  304 60 Pilsen, Czech Republic

Name: Prof. Dr. Marco Aiello
Affiliation: Institute for Architecture of Application Systems Service Computing

Name: Prof. Dr. Xiaomei Cong
Affiliation: School of Nursing, University of Connecticut, Storrs, CT, USA

Name: Prof. Dr. Hong-Sheng Wang
Affiliation: College of Medicine, University of Cincinnati, Cincinnati, OH, USA

Name: Dr. Sigve Nakken
Affiliation: Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

Name: Prof. Dr. Jochen Schneider
Affiliation: Department of Medical Translational Research, University of Luxembourg, Esch-sur-Alzette, Luxembourg

Name: Prof. Dr. Paraskevi Katsaounou
Affiliations: 1. Pulmonary Dept of First ICU Clinic, Evangelismos Hospital, 10676 Athens, Greece
2. School of Medicine, National and Kapodistrian University of Athens, 10561 Athens, Greece

Name: Dr. Ivo Bokoski
Affiliation: Digestive Endoscopy Unit, Fondazione Policlinico Universitario agostino Gemelli IRCCS, Largo A. Gemelli, 00168 Roma, Italy

Name: Prof. Dr. Carmen Burtea
Affiliation: Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, Faculty of Medicine and Pharmacy, University of Mons, Avenue Maistriau 19, Mendeleev Building, B-7000 Mons, Belgium

Name: Dr. Domenico Di Raimondo
Affiliation: Division of Internal Medicine and Stroke Care, Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (Promise) G. D'Alessandro, University of Palermo, Palermo, Italy

Name: Dr. Norio Yamamoto
Affiliations: 1. Department of Orthopedic Surgery, Miyamoto Orthopedic Hospital, Okayama, Japan
2. Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Name: Dr. Lea Bentur
Affiliation: Pediatric Pulmonary Institute, Ruth Children Hospital, Rambam Health Care Center, Haifa, Israel

We wish them every success both in their research and in the development of the journal.

Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/jpm/editors. 

JPM Editorial Office

We are pleased to announce that Prof. Dr. Kenneth P.H. Pritzker has been appointed Section Editor-in-Chief of “Clinical Medicine, Cell, and Organism Physiology”, Prof. Dr. K. Ray Chaudhuri has been appointed Section Editor-in-Chief of “Methodology, Drug and Device Discovery”, and Prof. Dr. Enrico Mini has been appointed Section Editor-in-Chief of “Pharmacogenetics” in the Journal of Personalized Medicine (JPM; ISSN 2075-4426). We look forward to their contribution to the continued success of the journal.

Name: Prof. Dr. Kenneth P.H. Pritzker
Affiliation: Professor Emeritus, Department of Laboratory Medicine and Pathobiology, Department of Surgery, University of Toronto, 6 Queens Pk Crescent W, F, Toronto, ON M5S 3H2, Canada
Interests: biomineralization: normal and pathological; pathogenesis of degenerative joint diseases, osteoarthritis; pathogenesis of crystal deposits in tissues; connective tissues as biomaterials; novel biomaterials; biomedical applications of fullerenes; connective tissue neoplasia; ribosomal RNA and its pathology; neoplasia risk assessment using novel biomarkers and histo-/cytomorphometry; ultrasound enabled histologic and cytologic technologies; novel biomarkers for spondylitis and other chronic inflammatory diseases; abiotic stress

Name: Prof. Dr. K. Ray Chaudhuri
Affiliation: Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, King's College London, Cutcombe Road, London SE5 9RT, UK
Interests: Parkinson's disease; movement disorders

Name: Prof. Dr. Enrico Mini
Affiliation: Department of Health Sciences, Universita degli Studi di Firenze, Florence, Italy
Interests: gastrointestinal cancers; tumor drug resistance; biomarkers; pharmacogenetics; pharmacogenomics; translational studies

JPM Editorial Office

On behalf of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), we would like to introduce a new feature, "Editor's choice articles", to highlight outstanding papers published in the journal. The Editor’s choice articles will be selected by the editors, and will include original articles that contain important and impactful findings, as well as review articles that are excellently written. With the introduction of this feature, readers can expect timely and useful highlights of recent articles in the journal, and deserving authors will receive more attention for their excellent contributions. We hope that this feature will enhance your reading pleasure and experience with JPM.

JPM Editorial Office

It is our great honor to congratulate the Editorial Board Members of JPM (ISSN: 2075-4426) who have been distinguished as Highly Cited Researchers in 2021 by Clarivate, according to the Web of Science data. We would like to express our gratitude for the immense impact the named researchers continue to have on scientific progress and our journal’s development.

Clarivate's annual list of Highly Cited Researchers^TM identifies the most highly cited scientists in the past decade. The impactful papers of these researchers are among the top 1% in the citation distribution of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Name: Prof. Dr. Adam J. Guastella

Affiliation: Brain and Mind Centre, The University of Sydney, Camperdown, NSW 2050, Australia

Name: Prof. Dr. Matthias Schwab

Affiliation: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology and Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA), University Hospital, Tuebingen Auerbachstrasse 112, 70376 Stuttgart, Germany

Name: Dr. Stuart A. Scott

Affiliation: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

The full list of Highly Cited Researchers for 2021 can be accessed at the following webpage in the Web of Science: https://recognition.webofscience.com/awards/highly-cited/2021/.

We would like to extend our sincerest congratulations to these individuals. In addition, we would like to acknowledge the professional support and valuable publications from all of our academic editors. 

JPM Editorial Office

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited Researchers^TM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of Science^TM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

• Have expertise and experience in the field related to the journal;
• Have received a Ph.D. in the last 10 years, approximately;
• Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
• Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

• 25 October 2021
  Energies journal and Institute of Mechanics, Chinese Academy of Sciences

• 28 October 2021
  Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University

• 29 October 2021
  Processes journal and Beijing Institute of Technology

• 29 October 2021
  Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

• Adriana Burlea-Schiopoiu;
• Alban Kuriqi;
• Álvaro González-Vila;
• Alessandro Alaimo;
• Alexey Beskopylny;
• Alexander Yu Churyumov;
• Alberto Fernández-Isabel;
• Andrea Mastinu;
• Antonios N. Papadopoulos;
• Anton Rassõlkin;
• Antonio Humberto Hamad Minervino;
• Arkadiusz Matwijczuk;
• Artur Słomka;
• Baojie He;
• Bartłomiej Potaniec;
• Bojan Đurin;
• Camilo Arturo Rodriguez Diaz;
• Carmelo Maria Musarella;
• Chiachung Chen;
• Chiman Kwan;
• Cristian Busu;
• Danil Pimenov;
• Dan-Cristian Dabija;
• Delfín Ortega-Sánchez;
• Demetrio Antonio Zema;
• Denis Butusov;
• Elena Lucchi;
• Gaurab Dutta;
• Livia Anastasiu;
• M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

We are happy to announce that we have compiled the Harvard papers we published between 2019 and 2020 into a book , since authors from Harvard Medical School published the greatest number of papers in JPM (ISSN: 2075-4426), and because these papers brought numerous good references to the attention of our readers. We invite you to read this book and encourage you to share it with your colleagues.

The book is available at
https://drive.google.com/file/d/1cW9NzC_QmAM7TcQKGovkZpWiO8UlsGny/view?usp=sharing.

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine:

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

We are pleased to announce that Prof. Dr. David Alan Rizzieri has been appointed Editor-in-Chief of Journal of Personalized Medicine (ISSN 2075-4426).

Prof. Dr. Rizzieri, MD, is a medical oncologist at the Duck Cancer Institute in Durham, NC, USA, and has over 30 years of experience in the medical field. He graduated from the University of Rochester School of Medicine in 1991. He is affiliated with Duke University Hospital.

He has been a member of the Combined International Bone Marrow Transplant Registry Lymphoma Writing Committee and is a member of the ALLIANCE (formerly CALGB) Leukemia Core Committee. He has served as chair or co-chair of multiple ALLIANCE lymphoma/ leukemia trials. He has led a team’s novel approaches for the care of patients using non-myeloablative allogeneic therapy to optimize a less toxic regimen for the transplant of patients with hematologic malignancies using haplo-identical, as well as matched donors. Furthermore, he has served on various NIH/NHLBI grant review committees and the ASH sub-committee on government affairs. He oversees the development and conduct of all clinical trials in adults with hematologic malignancies conducted in the Duke Cancer Institute. In recognition of his leadership and success in clinical research efforts, he was fortunate to receive the NIH “Clinical Investigator Team Leadership Award” in 2010 and was awarded the “Wendell Rosse Teaching Award” by the fellows in 2009.

He has published 457 peer-reviewed scientific papers with more than 10,000 citations. His research interests focus on the care of patients with hematologic malignancies, both with and without the use of bone marrow or stem cell transplantation. He focuses his research efforts on new approaches to manipulate minimal residual disease.

He will work closely with over 200 editorial board members from across the globe.

We warmly welcome Prof. Dr. David Alan Rizzieri in his role as Editor-in-Chief, and we look forward to him leading JPM to achieve more milestones.

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

• 10 journals received their first impact factor
• 96% of journals increased their impact factor from 2019
• 32 journals (38%) ranked among the top 25% of journals, in at least one category

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine:

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of JPM:

At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

We are pleased to announce that the first International Electronic Conference on Clinical Medicine (ECCM), chaired by Prof. Dr. Emmanuel Andrès, from the University Hospital of Strasbourg, France, and Prof. Dr. Michael G. Hennerici, from the University of Heidelberg, Germany, will be held on 15–30 September 2021 at Sciforum (https://sciforum.net/conference/ECCM).

The conference will cover all the multidisciplinary aspects of clinical medicine. The topics of interest include, but are not limited to, the following:

Cardiology

COVID-19

Gastroenterology and Hepatopancreatobiliary Medicine

Oncology

Infectious Diseases

Pulmonology

Hematology

Neurology and Stroke Neurology

Stomatology

Clinical Psychology

Psychiatry

Obstetrics and Gynecology

Endocrinology and Metabolism

Nephrology and Urology

Epidemiology and Public Health

Orthopedics

Dermatology

Ophthalmology

Otolaryngology

Nuclear Medicine and Radiology

Pharmacology

Anesthesiology

Emergency Medicine

The conference will be completely free of charge, both to attend and, for scholars, to upload and present their latest work on the conference platform. Accepted abstract submissions will be published in the proceedings of the conference, and authors are invited to develop their abstracts into full manuscripts, which will be considered for publication in JCM, with a 10% discount on the APC. JCM is an open access journal, published semimonthly by MDPI, in the field of clinical medicine. The journal is indexed in the Science Citation Index Expanded (SCIE IF = 3.303) and other databases. Full texts are archived in PubMed Central (PMC).

Important Dates

• Abstract Submission: 31 May 2021
• Acceptance Notification: 14 June 2021
• Full Paper Submission: 12 July 2021
• Conference Open: 15–30 September 2021

For more information on ECCM, please visit the conference website (https://sciforum.net/conference/ECCM) or contact us by email (eccm-2021@mdpi.com).

We are pleased to announce the winners of the JPM 2020 10th Anniversary Outstanding Reviewer Awards. The JPM Editorial Board and Editorial Team would like to express their gratitude for the time and energy dedicated by reviewers in checking the manuscripts submitted to JPM. It is due to their efforts that the high quality of the journal and quick turnaround have been maintained.

Each of them will receive a chance to publish one paper in JPM free of charge before 1 August 2021, 500 Swiss Francs, and a certificate to recognize their outstanding work. Please join us in congratulating the following winners:

Dr. Alain R. Thierry
Cancer Research Institute of Montpellier, INSERM, Montpellier, France
Research Interest: circulating DNA; clinical diagnostic and cancer; DNA auto-organization: synthetic biology, nanotechnology and gene therapy

Prof. Dr. Dirk Henrich
Department for Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, Frankfurt, Germany
Research Interest: cell culture; gene expression; flow cytometry; primary cell culture; inflammation; resuscitation; sepsis; tissue engineering; diabetes; immunology; innate immunity; stem cell biology

Dr. Francesca Mancuso
Department of Experimental Medicine, University of Perugia, Perugia, Italy
Research Interest: diabetes; transplant immunology; microencapsulation; pancreatic islets

Dr. Jacob J. Michaelson
Department of Psychiatry, University of Iowa, Iowa City, IA, USA
Research Interest: gene expression; genomics; gene regulation; regulation of gene expression; mutation; computational biology; genome sequencing; gene expression and chromatin biology; methylation; computational genomics

For more information about JPM awards, please see the following link: https://www.mdpi.com/journal/jpm/awards

We are pleased to announce that JPM became a monthly publication on 1 January, 2021. A monthly publication allows papers to be indexed in Web of Science and other indexing databases on a monthly basis rather than every 3 months, and they become searchable and are cited earlier. We also acknowledge the many valuable publications from our authors and the important contribution of our dedicated reviewers.

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of JPM:

JPM is currently establishing its Reviewer Board and Topics Board. If you are interested in a position on the Reviewer Board or have potential candidates to recommend, please contact the JPM Editorial Office (jpm@mdpi.com). We are looking forward to your support.

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

• eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
• creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
• promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
• raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
• supporting our members in achieving diversity and inclusion within their organizations.

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.

2) In the main text, there is a blank column on the left.

3) Small tables/figures are aligned on the left, large tables/figures are centered.

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.